Effect of vancomycin on the cytoplasmic membrane fatty acid profile of vancomycin-resistant and -susceptible isolates of Staphylococcus aureus

Journal of Infection and Chemotherapy

Volumn 19, Issue 1, 2013, Pages 24-33

  Mirani, Zulfiqar Ali ^a,b   Jamil, Nusrat ^b  

^a Pakistan Council of Scientific   (Pakistan)

^b UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Cytoplasmic membrane; Fatty acids; Staphylococcus aureus; Vancomycin resistance

Indexed keywords

FATTY ACID; FATTY ACID ESTER; MEMBRANE PHOSPHOLIPID; SATURATED FATTY ACID; UNSATURATED FATTY ACID; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FATTY ACID ANALYSIS; MASS FRAGMENTOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; VANA GENE; VANB GENE; VANC GENE; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS; VANCOMYCIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS;

EID: 84874115418     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0447-y     Document Type: Article

References (37)

1. Tolan RW Jr. Fascioliasis. 2007. http://www.emedicine.com.
2. Kinney KK. Treatment of infections caused by antimicrobial-resistant gram-positive bacteria. Am J Med Sci. 2010;340:209-17.
3. Tiwari HK, Sen MR. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect Dis. 2006;6:156.
4. Drago L, De Vecchi E, Nicola L, Gismondo MR. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections. BMC Infect Dis. 2007;7:111.
5. Walsh TR, Howe RA. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Annu Rev Microbiol. 2002;56:657-75.
6. Saderi H, Owlia P, Maleki Z, Habibi M, Rahmati N. Susceptibility to vancomycin in Staphylococcus aureus isolated from patients of four university-affiliated hospitals in Tehran. Iran J Pathol. 2008;3:161-6.
7. Saha B, Singh AK, Ghosh A, Bal M. Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (south Asia). J Med Microbiol. 2008;57:72-9.
8. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis. 2001;1:147-55.
9. Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev. 2010;23:99-139.
10. Perichon B, Courvalin P. Heterologous expression of the enterococcal vanA operon in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2004;48:4281-5.
11. Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science. 2003;302:1569-71.
12. Tenover FC, Weigel LM, Appelbaum PC, McDougal LK, Chaitram J, McAllister S, et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother. 2004;48:275-80.
13. Sakoulas G, Moellering RC. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin Infect Dis. 2008;46(Suppl. 5):S360-7.
14. Scheffers DJ, Pinho MG. Bacterial cell wall synthesis: new insights from localization studies. Microbiol Mol Biol Rev. 2005;69:585-607.
15. Kahne D, Leimkuhler C, Lu W, Walsh C. Glycopeptide and lipoglycopeptide antibiotics. Chem Rev. 2005;105:425-48.
16. Lundstrom TS, Sobel JD. Vancomycin trimethoprim-sulfomethaxazole and rifampicin. Infect Dis Clin North Am. 1995;9:747-67.
17. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 2000; 5th edn, vol 17, 2. Approved standard M7-A5. Wayne, National Committee for Clinical Laboratory Standards.
18. Charlesworth R, Warner M, Livermore DM, Wilson APR. Comparison of four methods for detection of teicoplanin resistance in methicillin resistant Staphylococcus aureus. J Antimicrob Chemother. 2006;58:186-9.
19. Miele A, Bandera M, Goldstein B. Use of primers selective for vancomycin resistant genes to determine van phenotype in Enterococci and to study gene organization in van (A) isolates. Antimicrob Agents Chemother. 1995;39:1772-8.
20. Chesneau O, Allignet J, el Solh N. Thermonuclease gene as a target nucleotide sequence for specific recognition of Staphylococcus aureus. Mol Cell Probes. 1993;7:301-10.
21. Rahman MM, Kolli VS, Kahler CM, Shih G, Stephens DS, Carlson RW. The membrane phospholipids of Neisseria meningitidis and Neisseria gonorrhoeae as characterized by fast atom bombardment mass spectrometry. Microbiology. 2000;146:1901-11.
22. Dieffenbacher A, Dyseller P. The determination of trans unsaturated fatty acids in edible oils and fats by capillary gas-liquid chromatography. Pure Appl Chem. 1997;69:1828-37.
23. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother. 1993;37:157-1563.
24. Miot M, Betton JM. Protein quality control in the bacterial periplasm. Microb Cell Fact 2004;3-4.
25. McNeil PL, Terasaki M. Coping with the inevitable: how cells repair a torn surface membrane. Nat Cell Biol. 2001;3:E124-9.
26. Beattie DS. The relationship of protein and lipid synthesis during biogenesis of mitochondrial membranes. J Membrane Biol. 1969;1:383-401.
27. Cronan JE. Bacterial membrane lipids: where do we stand? Annu Rev Microbiol. 2003;57:203-24.
28. Pierson DL, Mishra SK. Space flight, effects on microorganisms. Encycl Microbiol. 2000;4:344-52.
29. England LS, Gorzelaka M, Trevors JT. Growth and membrane polarization in Pseudomonas aeruginosa UG2 grown in randomized microgravity in a high aspect ratio vessel. Biochim Biophys Acta. 2003;1624:76-80.
30. Ohta T, Hirakawa H, Morikawa K, Maruyama A, Inose Y, Yamashita A, Oshima K, Kuroda M, Hattori M, Hiramatsu K, Kuhara S, Hayashi H. Nucleotide Substitutions in Staphylococcus aureus Strains, Mu50, Mu3, and N315. DNA Res. 2004;11:51-6.
31. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol. 2003;49:807-21.
32. Nielsen LE, Kadavy DR, Rajagopal S, Drijber R, Nickerson KW. Survey of extreme solvent tolerance in gram-positive cocci: membrane fatty acid changes in Staphylococcus haemolyticus grown in toluene. Appl Environ Microbiol. 2005;71:5171-6.
33. Kraus D, Peschel A. Staphylococcus aureus evasion of innate antimicrobial defence. Future Microbiol. 2008;3:437-51.
34. Whatmore AM, Reed RH. Determination of turgor pressure in Bacillus subtilis: a possible role for K+ in turgor regulation. J Gen Microbiol. 1990;136:2521-6.
35. D'Amico S, Collins T, Marx JC, Feller G, Gerday C. Psychrophilic microorganisms: challenges for life. EMBO Rep. 2006;7:2385-9.
36. Buttke TM, Jones SD, Bloch K. Effect of sterol side chains on growth and membrane fatty acid composition of Saccharomyces cerevisiae. J Bacteriol. 1980;144:124-30.
37. Annous BA, Kozempel MF, Kurantz MJ. Changes in membrane fatty acid composition of pediococcus sp. straJnrrl b-2354 in response to growth conditions and its effect on thermal resistance. Appl Environ Microbiol 1999;65:2857-62.